Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs SPDR Gold Trust (GLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs SPDR Gold Trust — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while SPDR Gold Trust trades at $379.79 (market cap $141.50B). The key difference: SPDR Gold Trust is far larger — about 4.6× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while SPDR Gold Trust pays none. Which is the better fit depends on your goals.
| GEHC | GLD | |
|---|---|---|
Market Cap | $31.07B | $141.50B |
Volume | 3,443,020 | 5,707,251 |
Sector | Health | — |
52-Week High | $88.16 | $495.90 |
52-Week Low | $59.48 | $362.32 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 75 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
GLD, tracking the price of gold, trades at $381.67, down 0.13% amid broader pressure from rising Treasury yields and a strong U.S. dollar. Technical indicators show a bearish bias with moving averages signaling sell pressure, while oscillators are neutral. Recent news highlights gold's struggle to maintain gains despite weak economic data, with support near $380. The absence of traditional stock fundamentals like P/E or revenue metrics reflects its nature as a commodity-backed ETF.
The outlook for GLD remains challenged by macroeconomic headwinds, including potential Federal Reserve rate hikes and elevated yields, which dampen gold's appeal. However, persistent inflation and geopolitical risks offer hedging opportunities. Risks include further dollar strength and yield increases, while any dovish Fed pivot could catalyze a rebound. Investors should weigh gold's role as a diversifier against ongoing monetary policy uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →
